Meet YHLO at 13th International Autoimmunity Congress in Greece

Why could YHLO do all these on diabetes diagnosis?

  • Accurate differential diagnosis between diabetes type 2 and LADA in Adults

  • Accurate prediction of the onset of type 1 diabetes

  • Elimination of lab results discrepancies in interpretation

 

YHLO achieve it through the cleverly combined interpretation of GADA, IAA, ZnT8A, ICA, and IA-2A!

Please find more about YHLO solutions on diabetes diagnosis...

 

We will be exhibiting at the #Autoimmunity2022! Join us to know more!

Follow @Autoimmunity2022 to stay updated & we will see you at our booth on 10 –13 June 

Attachments:

Previous

Officially Established, YHLO Japan R&D Center Set sail

YHLO showcased at 13th International Congress on Autoimmunity

Next

Previous Page

Officially Established, YHLO Japan R&D Center Set sail

Next Page

YHLO showcased at 13th International Congress on Autoimmunity

MORE NEWS

China-Hospeq 2026: YHLO Brings Diagnostic Solutions to Global Health Partners

China-Hospeq 2026: YHLO Brings Diagnostic Solutions to Global Health Partners

YHLO Brings Diagnostic Solutions to Global Health Partners at China-Hospeq 2026

2026-08-20

ADLM 2026: YHLO Brings Proven Lab Automation to the Americas

ADLM 2026: YHLO Brings Proven Lab Automation to the Americas

YHLO showcases its innovative products and academic achievements at ADLM 2026.

2026-08-01

YHLO at WHX Bangkok 2026: Innovation for Better Diagnostics

YHLO at WHX Bangkok 2026: Innovation for Better Diagnostics

2026-07-14